About RiboX
RiboX is a company based in Shanghai (China) founded in 2021. It operates as a B2B. RiboX offers products and services including Circular RNA Therapeutics. RiboX operates in a competitive market with competitors including Stoke Therapeutics, Vico, MiNA Therapeutics, ReNAgade and CureVac, among others.
- Headquarter Shanghai, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of RiboX
RiboX offers a comprehensive portfolio of products and services, including Circular RNA Therapeutics. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Engineered circular RNA for overcoming mRNA therapy limitations
Funding Insights of RiboX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investments & Acquisitions by RiboX
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - RiboX
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Ribox Comparisons
Competitors of RiboX
RiboX operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stoke Therapeutics, Vico, MiNA Therapeutics, ReNAgade and CureVac, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of antisense oligonucleotide drugs for treating inherited diseases by targeting RNA splicing
|
|
| domain | founded_year | HQ Location |
RNA modulating therapies for genetic neurological diseases are developed.
|
|
| domain | founded_year | HQ Location |
Small activating RNA therapeutics are developed to restore gene function.
|
|
| domain | founded_year | HQ Location |
RNA-based medicines are developed for treating multiple diseases.
|
|
| domain | founded_year | HQ Location |
mRNA-based therapeutics against cancer and infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Developer of RNA synthesis platform for gene therapeutics
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Ribox
Frequently Asked Questions about RiboX
When was RiboX founded?
RiboX was founded in 2021.
Where is RiboX located?
RiboX is headquartered in Shanghai, China.
What does RiboX do?
RiboX is a biotechnology company dedicated to the discovery and development of fully engineered circular RNA therapeutics. These innovations aim to address limitations of traditional mRNA therapies and enhance RNA-based medical treatments. The company operates globally, with headquarters in Shanghai, China, and additional offices in Beijing, China, Ness Ziona, Israel, and New Jersey, USA. RiboX focuses on research partnerships in the healthcare sector.
Who are the top competitors of RiboX?
RiboX's top competitors include MiNA Therapeutics, Vico and Stoke Therapeutics.
What products or services does RiboX offer?
RiboX offers Circular RNA Therapeutics.